Clinical Heterogeneity in Bronchiectasis. Recommended Reading from the Singapore Respiratory Medicine Fellows

Affiliations

¹ 1Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
² 2Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
³ 3Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore.
⁴ 4Department of Respiratory and Critical Care Medicine, National University Health System, Singapore; and.
⁵ 5Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Comment

Chee Kiang Phua et al. Am J Respir Crit Care Med. 2019.

. 2019 Aug 15;200(4):507-509.

doi: 10.1164/rccm.201901-0035RR.

¹ 1Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
² 2Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
³ 3Department of Respiratory and Critical Care Medicine, Changi General Hospital, Singapore.
⁴ 4Department of Respiratory and Critical Care Medicine, National University Health System, Singapore; and.
⁵ 5Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

No abstract available

Comment on

Clinical phenotypes in adult patients with bronchiectasis.
Aliberti S, Lonni S, Dore S, McDonnell MJ, Goeminne PC, Dimakou K, Fardon TC, Rutherford R, Pesci A, Restrepo MI, Sotgiu G, Chalmers JD. Aliberti S, et al. Eur Respir J. 2016 Apr;47(4):1113-22. doi: 10.1183/13993003.01899-2015. Epub 2016 Feb 4. Eur Respir J. 2016. PMID: 26846833
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study.
McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A, Dupont LJ, Fardon TC, Wilson R, Loebinger MR, Skrbic D, Obradovic D, De Soyza A, Ward C, Laffey JG, Rutherford RM, Chalmers JD. McDonnell MJ, et al. Lancet Respir Med. 2016 Dec;4(12):969-979. doi: 10.1016/S2213-2600(16)30320-4. Epub 2016 Nov 16. Lancet Respir Med. 2016. PMID: 27864036 Free PMC article.
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
Aksamit T, De Soyza A, Bandel TJ, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R. Aksamit T, et al. Eur Respir J. 2018 Jan 25;51(1):1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan. Eur Respir J. 2018. PMID: 29371384 Clinical Trial.